A detailed history of Scs Capital Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Scs Capital Management LLC holds 3,026 shares of NVS stock, worth $398,070. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,026
Previous 4,751 36.31%
Holding current value
$398,070
Previous $574,000 32.4%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$113.5 - $129.73 $195,787 - $223,784
-1,725 Reduced 36.31%
3,026 $388,000
Q2 2025

Aug 13, 2025

SELL
$101.96 - $121.01 $46,799 - $55,543
-459 Reduced 8.81%
4,751 $574,000
Q1 2025

May 14, 2025

BUY
$97.14 - $115.57 $506,099 - $602,119
5,210 New
5,210 $580,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Scs Capital Management LLC Portfolio

Follow Scs Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scs Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scs Capital Management LLC with notifications on news.